title: Variability in fluorouracil exposure during continuous intravenous infusion.
authors.affiliation: Institute of Pharmacy, Clinical Pharmacy, Center for Integrated Oncology (CIO), University of Bonn, and Department of Oncology, Internal Medicine, Johanniter Hospital, Bonn, Germany.
authors.forename: Tomi
authors.initials: T
authors.lastname: Hendrayana
authors.forename: Verena
authors.initials: V
authors.lastname: Kurth
authors.forename: Linda
authors.initials: L
authors.lastname: Krolop
authors.forename: Paul
authors.initials: P
authors.lastname: Kenny
authors.forename: Ralf Axel
authors.initials: RA
authors.lastname: Hilger
authors.forename: Ingo G H
authors.initials: IG
authors.lastname: Schmidt-Wolf
authors.forename: Yon-Dschun
authors.initials: YD
authors.lastname: Ko
authors.forename: Ulrich
authors.initials: U
authors.lastname: Jaehde
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019540:Area Under Curve; D001830:Body Surface Area; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D005240:Feasibility Studies; D005472:Fluorouracil / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil